59O A first-in-human, phase I study of BPI-371153, a novel small-molecule PD-L1 inhibitor, in advanced solid tumors or recurrent/refractory (r/r) lymphoma

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Annals of Oncology

Topics

Biology

Cancer Oncology

Physics

Medicine

Internal Medicine

Show all topics

DOI

10.1016/j.annonc.2024.10.080